318 related articles for article (PubMed ID: 15452072)
1. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.
Hayden BC; Jockovich ME; Murray TG; Voigt M; Milne P; Kralinger M; Feuer WJ; Hernandez E; Parel JM
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3644-9. PubMed ID: 15452072
[TBL] [Abstract][Full Text] [Related]
2. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
[TBL] [Abstract][Full Text] [Related]
4. Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
Carcaboso AM; Bramuglia GF; Chantada GL; Fandiño AC; Chiappetta DA; de Davila MT; Rubio MC; Abramson DH
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3761-7. PubMed ID: 17652749
[TBL] [Abstract][Full Text] [Related]
5. [Measurement and the clinical significance for the intraocular concentrations of carboplatin after systemic and local administration in rabbits].
Mao Y; Wu Z; Lin S; Li W
Yan Ke Xue Bao; 2004 Jul; 20(2):123-6. PubMed ID: 15301112
[TBL] [Abstract][Full Text] [Related]
6. Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.
Voigt M; Kralinger M; Kieselbach G; Chapon P; Anagnoste S; Hayden B; Parel JM
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3299-306. PubMed ID: 12356838
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
Ghate D; Brooks W; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
[TBL] [Abstract][Full Text] [Related]
9. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
10. In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.
Kalita D; Shome D; Jain VG; Chadha K; Bellare JR
Am J Ophthalmol; 2014 May; 157(5):1109-15. PubMed ID: 24503408
[TBL] [Abstract][Full Text] [Related]
11. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits.
Bodker FS; Ticho BH; Feist RM; Lam TT
Ophthalmic Surg; 1993 Jul; 24(7):453-7. PubMed ID: 8351091
[TBL] [Abstract][Full Text] [Related]
12. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
[TBL] [Abstract][Full Text] [Related]
13. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.
Grossman RE; Chu DF; Lee DA
Invest Ophthalmol Vis Sci; 1990 May; 31(5):909-16. PubMed ID: 2335452
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of carboplatin delivery to the eye using hydrogel-iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Dagan A; Frucht-Pery J; Pe'er J
Curr Eye Res; 2008 Mar; 33(3):269-75. PubMed ID: 18350438
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal carboplatin concentration and area under concentration versus time curve after intravitreal and periocular delivery.
Pochop P; Darsova D; Kukacka J; Tesfaye H; Vajner L; Uhlik J; Kodetová D; Malis J; Dotrelova D
Eur J Ophthalmol; 2010; 20(4):745-51. PubMed ID: 20306443
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
Abramson DH; Frank CM; Dunkel IJ
Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
[TBL] [Abstract][Full Text] [Related]
20. Measurement of intraocular concentrations of etoposide after systemic and local administration.
Mao Y; Wu Z; Yang H; Lin S; Zheng J
Yan Ke Xue Bao; 2004 Sep; 20(3):178-80, 186. PubMed ID: 15499727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
